1. Home
  2. SEPN vs PDFS Comparison

SEPN vs PDFS Comparison

Compare SEPN & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • PDFS
  • Stock Information
  • Founded
  • SEPN 2022
  • PDFS 1992
  • Country
  • SEPN United States
  • PDFS United States
  • Employees
  • SEPN N/A
  • PDFS N/A
  • Industry
  • SEPN
  • PDFS EDP Services
  • Sector
  • SEPN
  • PDFS Technology
  • Exchange
  • SEPN NYSE
  • PDFS Nasdaq
  • Market Cap
  • SEPN 1.0B
  • PDFS 1.1B
  • IPO Year
  • SEPN 2024
  • PDFS N/A
  • Fundamental
  • Price
  • SEPN $16.89
  • PDFS $27.88
  • Analyst Decision
  • SEPN Strong Buy
  • PDFS Strong Buy
  • Analyst Count
  • SEPN 4
  • PDFS 3
  • Target Price
  • SEPN $43.67
  • PDFS $42.33
  • AVG Volume (30 Days)
  • SEPN 432.4K
  • PDFS 180.5K
  • Earning Date
  • SEPN 02-15-2025
  • PDFS 02-13-2025
  • Dividend Yield
  • SEPN N/A
  • PDFS N/A
  • EPS Growth
  • SEPN N/A
  • PDFS 56.69
  • EPS
  • SEPN N/A
  • PDFS 0.11
  • Revenue
  • SEPN $981,000.00
  • PDFS $170,505,000.00
  • Revenue This Year
  • SEPN $406.62
  • PDFS $10.26
  • Revenue Next Year
  • SEPN N/A
  • PDFS $20.06
  • P/E Ratio
  • SEPN N/A
  • PDFS $253.36
  • Revenue Growth
  • SEPN N/A
  • PDFS 3.19
  • 52 Week Low
  • SEPN $15.86
  • PDFS $26.60
  • 52 Week High
  • SEPN $28.99
  • PDFS $39.70
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • PDFS 45.20
  • Support Level
  • SEPN N/A
  • PDFS $26.60
  • Resistance Level
  • SEPN N/A
  • PDFS $28.30
  • Average True Range (ATR)
  • SEPN 0.00
  • PDFS 0.89
  • MACD
  • SEPN 0.00
  • PDFS 0.03
  • Stochastic Oscillator
  • SEPN 0.00
  • PDFS 44.14

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

Share on Social Networks: